Skip to content

Effects of Preoperative Nebulized Lidocaine and Budesonide on Complications of Laryngeal Mask General Anesthesia in Fiberoptic Bronchoscopy Surgery: A Randomized Controlled Study

Effects of Preoperative Nebulized Lidocaine and Budesonide on Complications of Laryngeal Mask General Anesthesia in Fiberoptic Bronchoscopy Surgery: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109312
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway stenosis

Interventions

Combination Therapy Group:Nebulized lidocaine (2% solution, 5 ml) plus budesonide (1 mg/2 ml) was administered within 30 minutes before surgery.
Lidocaine Group:Nebulized lidocaine (2% solution, 5 ml) plus normal saline (2 ml) was administered within 30 minutes before surgery.
Control Group:Nebulized normal saline (7 ml) was administered within 30 minutes before surgery.

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years. 2. Scheduled to undergo fiberoptic bronchoscopy surgery. 3. ASA physical status classification of II-IV.

Exclusion criteria

Exclusion criteria: 1. Known allergy to lidocaine or budesonide. 2. Severe cardiac, hepatic, or renal dysfunction. 3. Pregnancy or lactation. 4. Recent use of corticosteroid medication. 5. Pre-existing severe psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
The incidence and severity of post-extubation cough.;

Secondary

MeasureTime frame
Intraoperative vital signs;The incidence of intraoperative bucking.;The incidence of rescue medication use.;Other intraoperative and postoperative adverse reactions (including airway spasm, hypoxemia, postoperative hoarseness, glottic edema, etc.);The amount of anesthetic drugs used during the operation;Patient operation time, anesthesia time, extubation time, PACU dwell time;

Countries

China

Contacts

Public ContactGangming Wu

The First Affiliated Hospital of Chongqing Medical University

317419592@qq.com+86 151 7883 2887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026